D.E. Shaw & Co
ABMD

D.E. Shaw & Co’s Abiomed Inc ABMD Stock Holding History

D.E. Shaw & Co’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,100
Closed -$270K – 5380
2022
Q3 		$270K Hold
1,100
– – ﹤0.01% 4347
2022
Q2 		$272K Sell
1,100
-12,100
-92% -$3.27M ﹤0.01% 4404
2022
Q1 		$4.37M Sell
13,200
-29,800
-69% -$9.17M ﹤0.01% 2469
2021
Q4 		$15.4M Buy
43,000
+4,000
+10% +$1.35M 0.01% 1281
2021
Q3 		$12.7M Buy
39,000
+10,000
+34% +$3.39M 0.01% 1332
2021
Q2 		$9.05M Sell
29,000
-11,200
-28% -$3.44M 0.01% 1574
2021
Q1 		$12.8M Sell
40,200
-4,500
-10% -$1.44M 0.01% 1203
2020
Q4 		$14.5M Sell
44,700
-15,000
-25% -$4.15M 0.01% 1137
2020
Q3 		$16.5M Buy
59,700
+30,700
+106% +$8.84M 0.02% 942
2020
Q2 		$7M Buy
29,000
+20,200
+230% +$4.06M 0.01% 1416
2020
Q1 		$1.28M Sell
8,800
-11,300
-56% -$1.88M ﹤0.01% 2546
2019
Q4 		$3.43M Buy
20,100
+2,800
+16% +$519K ﹤0.01% 2043
2019
Q3 		$3.08M Sell
17,300
-1,100
-6% -$238K ﹤0.01% 2038
2019
Q2 		$4.79M Sell
18,400
-25,200
-58% -$6.69M 0.01% 1618
2019
Q1 		$12.5M Sell
43,600
-18,200
-29% -$6.05M 0.02% 969
2018
Q4 		$20.1M Buy
61,800
+17,700
+40% +$6.15M 0.03% 708
2018
Q3 		$19.8M Buy
44,100
+1,200
+3% +$473K 0.02% 782
2018
Q2 		$17.5M Buy
42,900
+600
+1% +$217K 0.02% 782
2018
Q1 		$12.3M Buy
42,300
+20,000
+90% +$5.07M 0.02% 888
2017
Q4 		$4.18M Buy
+22,300
New +$4.16M 0.01% 1617
2017
Q1 		– Sell
-47,200
Closed -$5.32M – 3680
2016
Q4 		$5.32M Buy
47,200
+1,900
+4% +$220K 0.01% 1322
2016
Q3 		$5.83M Buy
+45,300
New +$5.43M 0.01% 1198

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

D.E. Shaw & Co's ABMD Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,448 shares — an estimated $847K sold.

D.E. Shaw & Co first reported a position in ABMD in Q2 2013 and held it in 34 quarters. The position peaked at $39.1M in Q3 2016. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,448 Abiomed Inc shares in Q4 2022, an estimated $847K.
  • D.E. Shaw & Co first reported a position in Abiomed Inc in Q2 2013 and held it in 34 quarters.
  • D.E. Shaw & Co's Abiomed Inc position peaked at $39.1M in Q3 2016.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.